Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine

Publisher： Karger

E-ISSN： 1423-0232|73|5-6|426-429

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.5-6, 2008-06, pp. : 426-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3290-3297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

By  

Oncology Research and Treatment, Vol. 35, Iss. 10, 2012-09 ,pp. : 576-580

Karger

Access to resources Recommend Favorite

Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin

By  

Urologia Internationalis, Vol. 92, Iss. 2, 2013-11 ,pp. : 180-185

Karger

Access to resources Recommend Favorite

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite